---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-227749"
form_type: "8-K"
ticker: "FATE"
cik: "0001434316"
company_name: "FATE THERAPEUTICS INC"
filed_at: "2023-09-01T23:59:59+00:00"
generated_at: "2026-06-11T00:26:57.758529+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Fate Therapeutics loses summary judgment in patent case against Shoreline; plans appeal

## Summary
- Court granted Shoreline's summary judgment of non-infringement on Whitehead Patents covering iPSC technology.
- Fate strongly disagrees with ruling and will consider appeal; validity and enforceability of patents unaffected.
- State case for breach of contract and fraud against Shoreline ongoing; trial set for January 2024.
- Shoreline argued it purchases iPSC lines from third parties, not directly infringing Fate's patents.

## SEC filing metadata
- accession: 0001193125-23-227749
- form_type: 8-K
- ticker: FATE
- cik: 0001434316
- company_name: FATE THERAPEUTICS INC
- filed_at: 2023-09-01T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434316/000119312523227749/0001193125-23-227749-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434316/000119312523227749/d549067d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-227749
- JSON: https://secwatch.observer/filing/0001193125-23-227749.json
- Plain text: https://secwatch.observer/filing/0001193125-23-227749.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.